Tonix Pharmaceuticals Holding TNXP
NASDAQ TNXP
$9.23 -0.51 (-5.24%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tonix Pharmaceuticals Holding (TNXP) Liabilities and Shareholders Equity (2010 - 2026)

Updated

Tonix Pharmaceuticals Holding's Liabilities and Shareholders Equity was $254.09 million in Q2 2026, up 35.6% from $187.36 million a year earlier but down 1.5% from the prior quarter.

Analysis

Tonix Pharmaceuticals Holding (TNXP) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Tonix Pharmaceuticals Holding came in at $277.17 million, up 70.2% from FY2024.

  • Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 23.1% (FY2020 to FY2025).
  • In earlier years, Liabilities and Shareholders Equity was $162.89 million in FY2024 (+5.5%), $154.46 million in FY2023 (-31.6%), $225.69 million in FY2022 (-6.3%) and $240.9 million in FY2021 (+145.4%).
  • Quarterly Liabilities and Shareholders Equity has moved between $70.31 million (Q2 2024) and $277.17 million (Q4 2025) over five years.
  • Compared with a year earlier, Liabilities and Shareholders Equity has increased for seven straight quarters, with growth averaging 61.0% over the last eight quarters.
  • The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q3 2021 (growth of 217.6%); the worst was Q2 2024 (a decline of 56.0%).
  • Per Business Quant data, TNXP's Liabilities and Shareholders Equity in the three quarters before Q2 2026 was $257.91 million (Q1 2026), $277.17 million (Q4 2025) and $252.44 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Tonix Pharmaceuticals Holding 163.56 Mn 163.56 Mn 12.84 Mn 254.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 254.09 Mn
Mar 31, 2026 257.91 Mn
Dec 31, 2025 277.17 Mn
Sep 30, 2025 252.44 Mn
Jun 30, 2025 187.36 Mn
Mar 31, 2025 192.87 Mn
Dec 31, 2024 162.89 Mn
Sep 30, 2024 94.99 Mn
Jun 30, 2024 70.31 Mn
Mar 31, 2024 135.34 Mn
Dec 31, 2023 154.46 Mn
Sep 30, 2023 139.28 Mn
Jun 30, 2023 159.74 Mn
Mar 31, 2023 179.09 Mn
Dec 31, 2022 225.69 Mn
Sep 30, 2022 242.65 Mn
Jun 30, 2022 276.17 Mn
Mar 31, 2022 223.72 Mn
Dec 31, 2021 240.90 Mn
Sep 30, 2021 214.77 Mn
API Access

Tonix Pharmaceuticals Holding Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TNXP&period=max&api_key=YOUR_API_KEY